Screener
Syndax Pharmaceuticals SNDX Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
The source filing: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-197154
FAQ
- What is Syndax Pharmaceuticals's total debt?
- Syndax Pharmaceuticals (SNDX) reported total debt of $350.49M in Q1 2026.
- How has Syndax Pharmaceuticals's total debt changed year-over-year?
- Syndax Pharmaceuticals's total debt increased by 4.2% year-over-year, from $336.23M to $350.49M.
- What is the long-term trend for Syndax Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's total debt has grown at a 284.7% compound annual growth rate (CAGR), from $417K to $351.52M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Syndax Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude